Cognitive impairment is a core symptom domain of schizophrenia. The effect of antipsychotics,
the cornerstone of treatment in schizophrenia, on this domain is not fully clear. There is …

Transcranial direct current stimulation (tDCS) is an upcoming treatment modality for patients
with schizophrenia. A series of recent observations have demonstrated improvement in …

COVID-19 can worsen the physical health of individuals with serious mental illness, a
vulnerable group already facing physical health disparities. COVID-19 is further reducing access …

Schizophrenia (SCZ) is a psychiatric disorder characterized by a wide range of positive,
negative and cognitive symptoms, along with an increased risk of metabolic syndrome and …

Persistent auditory verbal hallucinations (AVH) that are refractory to antipsychotic medications
are reported in about 20–30% of schizophrenia patients. Transcranial Direct Current …

Impaired insight in schizophrenia patients has been linked with prefrontal deficits. In this
open-label study, we examined for potential insight facilitation effects of add-on tDCS (with …

Hypothalamic detection of elevated circulating glucose triggers suppression of endogenous
glucose production (EGP) to maintain glucose homeostasis. Antipsychotics alleviate …

JCN is supported by the INSPIRE faculty award by the Department of Science and Technology,
Government of India (IFA12-LSBM-26). DJ is supported by the Department of Science …

Schizophrenia is a debilitating psychiatric illness that remains poorly understood. While the
bulk of symptomatology has classically been associated with disrupted brain functioning, …

Schizophrenia (SCZ) is a severe mental disorder with high morbidity and lifetime disability
rates. Patients with SCZ have a higher risk of developing metabolic comorbidities such as …